The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I), or a pharmaceutically acceptable salt thereof, and its therapeutic use.
申请公布号
AU2013308504(B2)
申请公布日期
2016.11.10
申请号
AU20130308504
申请日期
2013.08.30
申请人
Tetraphase Pharmaceuticals, Inc.
发明人
Xiao, Xiao-Yi;Clark, Roger B.;Hunt, Diana Katharine;Sun, Cuixiang;Ronn, Magnus;Zhang, Wu-Yan;He, Minsheng
